Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pro-apoptotic signaling proteins are a functional class of intracellular molecules that initiate and execute programmed cell death (apoptosis). This group primarily comprises members of the Bcl-2 family, including effectors like BAX and BAK, and BH3-only proteins such as BIM, PUMA, and NOXA, as well as the caspase family of proteases [1][3]. These proteins are critical for maintaining cellular homeostasis by eliminating damaged or redundant cells; however, their dysregulation is a hallmark of various diseases. In many cancers, pro-apoptotic proteins are suppressed or sequestered by overexpressed anti-apoptotic proteins (e.g., BCL-2, BCL-XL), allowing malignant cells to survive despite oncogenic stress [2]. Therapeutic strategies, most notably BH3 mimetics like Venetoclax, work by binding to anti-apoptotic proteins, thereby releasing pro-apoptotic factors to trigger mitochondrial outer membrane permeabilization (MOMP) and subsequent cell death [4]. While highly effective in certain hematologic malignancies, targeting these pathways requires careful management of safety concerns such as tumor lysis syndrome and myelosuppression [3].
Induction of mitochondrial outer membrane permeabilization (MOMP) through the displacement of pro-apoptotic BH3-only proteins from anti-apoptotic proteins or direct activation of BAX/BAK, leading to the activation of the caspase cascade [1][3][4].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pro-apoptotic signaling proteins.